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Abstract
Sporadic non-ampullary duodenal adenoma (SNADA) is a rare disease, and therefore, its clinical characteristics have not been
comprehensively investigated. Furthermore, owing to the high complication rates and severity of endoscopic resection, treatment
strategies vary among facilities. In the present study, we aimed to clarify the clinical characteristics and course of SNADA.
We extracted clinical and histological records of SNADA cases diagnosed in 11 hospitals between September 1999 and August
2014. The patients were divided into “no-resection” and “resection” groups based on the initial treatment approach. We investigated
the long-term outcome of the “no-resection” group and treatment results of the “resection” group, with particular interest in
endoscopic resection.
Overall, 299 patients were diagnosed with SNADA. The median age at diagnosis was 67years (range, 31–88years), with
approximately twice as many men as women. The median tumor size was 8.0mm (2–60mm). In total, 161 patients were initially
selected for no-resection and 138 underwent resection. Age>70years and the presence of either severe illness or poor performance
status were significantly related to opting for no-resection. In the no-resection group, 101 patients underwent endoscopic follow-up
for at least 1 year. During the observational period (2.5±2.2years), 27 lesions (27%) disappeared following cold forceps biopsy, and
13 lesions (14%) presented lateral growth. Four lesions (4%) changed to mucosal carcinoma, 3 were treated endoscopically, and 1
was surgically resected. Nineteen patients died; however, no one died of duodenal carcinoma. In the endoscopic resection group, en
bloc resection was achieved in 78%of patients. However, the complication rate for perforation was 7%, and endoscopic submucosal
dissection was associated with a 36% perforation rate.
With the low incidence of cancer development and no disease specific death, the strategy of initially not performing resection could
be considered especially for the older adults, poor-prognosis patients, or small lesions.
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Abbreviations: EGD = esophagogastroduodenoscopy, EMR = endoscopic mucosal resection, ESD = endoscopic submucosal
dissection, FAP = familial adenomatous polyposis, SNADA = sporadic non-ampullary duodenal adenoma.
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1. Introduction
Non-ampullary duodenal adenomas are rare tumors of the
gastrointestinal tract.[1] With growing opportunities to perform
esophagogastroduodenoscopy (EGD), the rate at which non-
ampullary duodenal adenoma is detected might be increasing.
Although familial adenomatous polyposis (FAP) and MUTYH-
associated polyposis are recognized as a condition that pre-
disposes patients to this disease, several cases are sporadic and are
incidentally detected.
It has been postulated that a duodenal adenoma follows the
same adenoma-carcinoma sequence as colonic adenomas.[2]
Based on this hypothesis, it is crucial to resect the lesion before it
progresses into carcinoma. Previously, some reports have
elaborated on the natural history of duodenal adenoma in
FAP.[3,4] One study has investigated the natural history of
sporadic non-ampullary duodenal adenoma (SNADA) and noted
that it was associatedwith a low risk of cancerization[5]; however,
there have been little reports on the natural history of SNADA.
Furthermore, while some reports have focused on surgical
resection, others have emphasized endoscopic resection techni-
ques, including endoscopic mucosal resection (EMR) and
endoscopic submucosal dissection (ESD).[6–15] Although endo-
scopic resection is the method most commonly employed to treat
SNADA, it is associated with a higher rate of complications and
more severe complications than gastric and colonic treat-
ment.[10,12,13] Although ESD tends to be performed for larger
lesions, the perforation rate reportedly ranges between 8% and
50%, even when performed at specialized institutions.[8–13]
Surgical treatment has been described as safe, and complete
resection can be achieved[14]; however, it is associated with a
higher degree of surgical stress than endoscopic treatment.
Furthermore, several previous reports were those from high-
volume centers, and the complication rate in general hospitals is
predicted to be higher than the rates described in previous studies.
As resection of lesions is associated with a non-negligible risk
of complications, not all patients undergo resection, with some
patients simply observed without performing resection in real-
world clinical settings. In the present study, we performed a
retrospective multicenter observational study to clarify the
clinical characteristics and course of SNADA by following the
course of patients who underwent observation without resection
and those who underwent resection.
2. Methods
2.1. Study design
We enrolled patients with non-ampullary duodenal adenoma
who were histologically diagnosed at 11 hospitals from
November 1999 to April 2014. The inclusion criteria were as
follows: histologically diagnosed as duodenal adenoma located in
the duodenum. Patients with lesions located on or connected to
the ampulla and those diagnosed with FAP or MUTYH-
associated polyposis were excluded from the present study.
The included cases were collected from the clinical database of
pathology departments at each facility. Although only consecu-
tive cases were enrolled, the inclusion period differed among
participating facilities. The study protocol was approved by the
ethics committees of Okayama University Hospital and affiliated
hospitals, and informed consent was obtained using an opt-out
method.
2.2. Data collection
The following clinicopathological data were collected from
patients’ medical records: age, sex, medical history, comorbidity
of malignant tumor, Eastern Cooperative Oncology Group
Performance Status, the reason for receiving endoscopy, lesion
site, tumor size, morphological type, initial treatment method,
treatment result, complications, survival outcome, and cause of
death. In cases involving patients with multiple lesions, the lesion
with the largest size or highest grade was adopted for the baseline
characteristics and analysis of the long-term outcome. Histologi-
cal grade was categorized based on the Vienna classification.[16]
We considered Vienna classification category 3 (low-grade
adenoma), 4.1 (high-grade adenoma), and ≥4.2 as carcinoma.
The patients were divided into the no-resection and resection
groups based on the initial treatment approach, which was
decided at each facility after a discussion between patients and
physicians. Patients who did not undergo resection within 1 year
of the SNADA diagnosis were classified into the no-resection
group; those who underwent resection within 1 year were
classified into the resection group.
Survival outcome and cause of death were investigated in all
patients in the no-resection group. Moreover, to investigate the
long-term outcomes of endoscopic findings of the lesions, we
examined changes in lesion size and performed a histological
assessment during the observational period. In the no-resection
group with endoscopic follow-up analysis, cases in which the
endoscopic follow-up period was less than 1 year (except for
patients in whom the lesion disappeared within 1 year) were
excluded.
The analysis of endoscopic treatment outcomes included cases
in which endoscopic resection was performed by any method and
at any time. The analysis of factors associated with endoscopic
treatment outcomes included the endoscopic procedure, en bloc
resection rate, and complications.
2.3. Statistical analyses
Wilcoxon rank-sum test was used to compare continuous
variables. The x2 test or Fisher exact test was used to compare
categorical variables. The cutoff points of lesion size for lesions
that disappeared or grew were determined by receiver operator
characteristics curve analysis. The Kaplan-Meier method was
used to represent the survival outcome. Two-sided P values <.05
were considered to indicate statistical significance. All statistical
analyses were performed using the JMP Pro software program
(version 12; SAS Institute Inc., Cary, NC).
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3. Results
3.1. Patient and lesion characteristics
This multicenter retrospective study included 303 lesions in 299
patients. Table 1 shows the characteristics of all patients and
lesions. The male:female ratio was approximately 2:1. EGD was
mainly performed for screening purposes. The lesion locations
were almost evenly distributed between the oral side of the Vater
and the anal side of the Vater. Moreover, superficial-type lesions
were approximately twice as frequent as protruded-type lesions.
3.2. Analysis of factors associated with the selection of
the initial treatment strategy
The patient flow is shown in Figure 1. In total, 161 patients were
initially selected for no-resection. Overall, 142 lesions in 138
patients were initially treated by endoscopic or surgical resection.
Table 2 shows the initial treatment strategy according to patient
and lesion characteristics. The option of no-resection was more
significantly and frequently selected in patients >70years of age
and those with severe illness or Eastern Cooperative Oncology
Group Performance Status >2. In contrast, resection was
significantly more frequently selected in cases involving lesions
>10mm in size and protruded-type lesions.
3.3. Long-term outcomes of no-resection group
During the median observation period of 2.3years (0–11.4), 19
patients died (see Figure S1, Supplemental Digital Content, http://
links.lww.com/MD2/A505 which shows the Kaplan-Meier plots
for survival of no-resection group). Ten patients died owing to
malignant neoplasia; of the remaining 9 patients, 1 patient each
died of the following causes: alcoholic liver dysfunction, renal
dysfunction, rupture of aortic aneurysm, CREST (calcinosis,
Raynaud phenomenon, esophageal dysmotility, sclerodactyly,
and telangiectasia) syndrome, thromboangiitis obliterans, old
age, suicide, sudden death, and unknown cause. No patient died
of duodenal carcinoma.
After excluding 60 patients who did not receive follow-up
endoscopy or who underwent endoscopic follow-up for less than
1year, 101 patients were investigated in the no-resection with
Table 1
The patient and lesion characteristics.
Patients 299
Age (median, range) year 67 (31–88)
Male/female 185/114
Comorbidity of malignancy
All (%) 75 (25)
Colorectal cancer (%) 14 (5)
Gastric cancer (%) 28 (10)
Others (%) 39 (16)














Anal-Vater = anal side of the Vater, LGA = low-grade adenoma, HGA = high-grade adenoma, oral-
Vater = oral side of the Vater.
Figure 1. Patient flow.
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endoscopic follow-up group. During the median observation
period of 2.7years (0.2–11.4), several patients showed no
marked change in lesion size (51/101, 50%); in 27 (27%) cases,
the lesions disappeared, while the lesions shrank in 10 (10%)
cases and grew in 13 (13%) cases (Fig. 2). Thirteen of these
lesions were ultimately resected during follow-up owing to the
following reasons: lesion growth (n=6), a change into carcinoma
(n=2) as assessed by biopsy specimens, or because the patient
indicated that they wished to undergo resection (n=5). The
histological diagnosis was altered to carcinoma in 4 cases (4%).
Three lesions were treated endoscopically and 1 was surgically
resected. All lesions were finally diagnosed as mucosal carcino-
ma. These lesions had been followed for 608, 652, 1353, and
1554days before resection, with 3 lesions found to be enlarged
during follow-up. The morphology was superficial elevated type
in 3 cases and protruded-type in 1 case, with no lesion presenting
morphological change.
Univariable analyses were performed to determine the factors
associated with the disappearance and enlargement of lesions
(Table 3). The cutoff values of lesion sizes for disappearance and
enlargement were <6mm and >10mm, respectively, and were
determined by receiver operator characteristics curve analysis.
Using these cutoff values, the sensitivity, specificity, and area
under the curve for lesion disappearance were 92.6%, 71.6%,
and 0.879, respectively, and were 76.9%, 72.7%, and 0.762, for
lesion enlargement, respectively. Univariate analyses revealed
that a lesion size <6mm was significantly associated with lesion
disappearance (odds ratio, 31.54 [95% confidence interval (CI):
8.40–207.21], P< .001), and a lesion size >10mm was
significantly associated with lesion enlargement (odds ratio
8.89 [95% CI: 2.48–42.22], P< .001).
3.4. Short-term outcome of resection group
In the no-resection group, 13 lesions underwent resection after at
least 1year of follow-up, and the data related to resection were
included in the endoscopic resection analysis (Table 4). Overall,
129 lesions underwent endoscopic resection, while 26 lesions
were surgically treated. There were no cases of additional surgery
following endoscopic resection because of the recurrence risk of
cancer. Surgical treatment was selected because of a large tumor
size, diagnosis of cancer, or difficulty of endoscopic resection in
each hospital. The en bloc resection rate of the endoscopic
treatment was 78% (101/129). The complication rate was 9%
(11/129), with perforation observed in 9 cases and post-
intervention bleeding in 2 cases. There were 2 treatment
strategies: EMR and ESD (EMR, n=118; ESD, n=11). The
patients who received ESDwere significantly younger than that of
those who underwent EMR. Although the en bloc resection rates
of EMR and ESD were 78% and 82%, respectively, the
perforation rate following ESD was significantly higher than
that observed with EMR (36% and 4%, respectively). The
univariate analysis of factors associated with perforation showed
that the treatment strategy of ESD, when compared with EMR,
was significantly associated with perforation (odds ratio 12.91
[95% CI: 2.71–60.91], P= .002) (see Table S1, Supplemental
Digital Content, http://links.lww.com/MD2/A506 which shows
the univariable analysis of factors associated with perforation).
Three lesions were not subjected to a histological evaluation after
Table 2






Over 70 years of age 77 (48%) 43 (31%) .004
Comorbidity of severe
illness or ECOG-PS>2






Size (over 10 mm) 32 (20%) 68 (48%) <.001
Histology (HGA) 9 (6%) 16 (11%) n.s
Morphology (protruded) 45 (28%) 61 (43%) .007
Location (oral-Vater) 67 (42%) 78 (55%) n.s
ECOG-PS = Eastern Cooperative Oncology Group Performance Status, HGA = high-grade adenoma,
n.s = not significant, oral-Vater = oral side of the Vater.
Figure 2. The change in the tumor size between the initial endoscopic examination and the final examination in the no-resection group.
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resection, while 126 lesions underwent histological examination
after resection. Although all lesions were diagnosed as adenoma
using a biopsy specimen, the histological diagnosis of 22 lesions
(18%) was altered to carcinoma after resection. Univariate
analysis showed that the only factor associated with a diagnostic
change to carcinoma was a histological diagnosis of high-grade
adenoma before resection (see Table S2, Supplemental Digital
Content, http://links.lww.com/MD2/A507 which shows the
univariable analysis of characteristics associated with lesion
diagnosed as carcinoma after endoscopic resection).
4. Discussion
The present study included 299 SNADA patients who were
managed at 11 institutions. As in previous reports,[10,12] patients
were predominantly male, with a median age of 67years. In
several cases, the lesion was detected incidentally by EGD
screening, and 25% of patients had malignant comorbidities.
A previous report has described gastric cancer and colorectal
cancer as comorbidities of SNADA.[17] The same tendency was
observed; however, this relationship could be attributed to
gastrointestinal malignant tumor patients tending to undergo
EGD, resulting in the incidental detection of these lesions.
Regarding the treatment strategy, approximately 50% of the
patients underwent treatment, while the remainder were initially
observed without resection. Although endoscopic treatment of
gastrointestinal superficial tumors is the standard practice in
Japan, the risk of complications, particularly perforation, is well
known in clinical settings.[18] In the present study, a no-resection
treatment strategy was generally applied in selected patients
predicted to have a poor prognosis or smaller lesions. None of the
patients in the no-resection group died because of duodenal
cancer. Furthermore, 19 deaths were recorded because of other
causes. Although a short observation period must be considered,
our findings suggest that observation without resection may be a
viable strategy for cases with a poor performance status and those
expected to have a poor prognosis.
Four lesions (4%) in the no-resection group were diagnosed
with carcinoma during the observational period. All cases were
ultimately diagnosed as mucosal carcinoma and were cured by
Table 3
The results of a univariable analysis of the characteristics associated with lesion disappearance and enlargement.
n Odds ratio (95% confidence interval) P
Disappearance

























































Anal-Vater = anal side of the Vater, HGA = high-grade adenoma, LGA = low-grade adenoma, n.s = not significant, oral-Vater = oral side of the Vater.
Table 4
The en bloc resection and complication rates of EMRand ESD. Therewas no significant difference in the en bloc resection rates; however,
the perforation rate was significantly higher in the ESD group. P value shows the difference between EMR and ESD.
All (n=129) EMR (n=118) ESD (n=11) P
Age (median, range, year) 66 (34–85) 67 (34–85) 57 (45–66) .002
Male/female 77 / 52 71 / 47 6 / 5 n.s
Size (median, range, mm) 10 (2–25) 10 (2–40) 10 (5–25) n.s
Location (anal-Vater) 72 (56%) 66 (56%) 6 (55%) n.s
Morphology (superficial) 74 (57%) 64 (54%) 10 (91%) .04
Histology after resection
LGA/HGA/carcinoma/not evaluated 94 (73%)/10 (8%)/22 (17%)/3 (2%) 86 (73%)/10 (8%)/19 (16%)/3 (2%) 8 (73%)/0 (0%)/3 (27%)/0 (0%) n.s
En bloc resection 101 (78%) 92 (78%) 9 (82%) n.s
Complication 11 (9%) 7 (6%) 4 (36%) <.001
Perforation 9 (7%) 5 (4%) 4 (36%) <.001
Postbleeding 2 (2%) 2 (2%) 0 (0%) n.s
Anal-Vater = anal side of the Vater, EMR = endoscopic mucosal resection, ESD = endoscopic submucosal dissection, HGA = high-grade adenoma, LGA = low-grade adenoma, n.s = not significant.
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local resection. In FAP cases, the incidence of duodenal
carcinoma is 3%, despite the occurrence of duodenal adenomas
in most patients.[19] Numerous small duodenal adenomas are
followed up for several years.[20,21] Careful monitoring is
required for carcinogenesis; however, observation without
resection could be considered for SNADA as similar to FAP.
Lesions <6 mm in size were predicted to disappear during
follow-up; this was predicted with high sensitivity and area under
the curve. This phenomenon could be attributed to the
performance of cold forceps biopsy. Generally, a pre-treatment
biopsy should be avoided owing to the risk of biopsy-induced
fibrosis, which can hamper endoscopic resection.[15] However, in
the present study, small lesions could be resolved by cold forceps
biopsy, which might be a feasible approach for performing cold
forceps polypectomy for small lesions. Based on this finding, we
are conducting a prospective study on the efficacy of cold forceps
polypectomy for <6mm which was registered at the University
Hospital Medical Information Network 000025913. In contrast,
a 12mm lesion, initially diagnosed in 1 patient had grown over
60mm in size by the 7-year follow-up (Fig. 3). On histological
examination, the final biopsy specimen was revealed as a low-
grade adenoma, and hence, follow-up continued; however,
endoscopic resection might be increasingly difficult and riskier
than before owing to the size and biopsy-induced fibrosis.
Although the sensitivity and specificity were not substantially
high, certain lesions >10mm may increase in size. These lesions
should be considered for the resection at the initial diagnosis.
ESD tended to be performed in younger patients or those
presenting superficial-type lesions, and the lesion size, location,
and en bloc resection rate were approximately the same as that of
patients who underwent EMR. The target lesions undergoing
ESD were not exceedingly large, and hence, a 36% perforation
rate is unacceptable for clinical application at a general hospital.
Certain reports have described the clear benefits of ESD over
EMR in terms of achieving complete resection of large tumors.[8–
11,13–15] However, considering the high perforation rate, ESD
should only be performed for SNADA at specialized institutions
and not at general hospitals. Several studies have highlighted
strategies for the prevention of perforation after duodenal
ESD.[22,23] The endoscopic closure method is one such promising
technique, with the widespread clinical use of this method being
highly desired. There have been several reports on piecemeal
EMR for SNADA.[24–26] Although the local recurrence rate in
these reports was non-negligible, many such cases were safely and
completely managed by re-endoscopic treatment. Given the
perforation risk, piecemeal EMRmight be an acceptable strategy
for treating large lesions in general hospitals. Furthermore,
underwater EMR has been reported as a safe and effective
Figure 3. The disappearance and growth of lesions in the no-resection group. (A) A 4-mm superficial elevated lesion can be observed in the descending part of the
duodenum. A cold forceps biopsy was performed, and the histological diagnosis is low-grade adenoma. (B) No residual tumor can be observed after 16years. (C) A
12-mm superficial elevated lesion can be observed at the inferior duodenal flexure. The histological diagnosis of a biopsy specimen is low-grade adenoma. (D) The
lesion grew to over 60mm over a 7-year period; however, the histological diagnosis remains low-grade adenoma.
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SNADA treatment method.[27,28] Cold polypectomy is a safe and
effective treatment strategy for small SNADA lesions.[29] With
the development of safety treatment methods, the selection of no-
resection may be decreased. However, for patients who expected
to have a poor prognosis, the necessity of resection for the patient
should be fully considered.
Our study had several limitations. First, this was a retrospective,
multicenter study. Differences in treatment strategies and follow-
upmethodsamong institutions and timepointsmay cause selection
bias and compromisedata quality.However, considering the rarity
of SNADA, a retrospective analysis may be acceptable. Further-
more, to avoid selection bias, we collected data on both non-
resected and resected cases as a multifacility trial. Second,
histological assessments were performed in each hospital. The
histological diagnosis of duodenal epithelial tumors is challenging
even when performed by an expert pathologist. Although we
confirmed that there were qualified pathologists with expertise
in gastroenterology at all institutions, differences among the
pathologists might have resulted in uncertainty in the histological
grade, or whether neoplastic or non-neoplastic. However, we
believe that the analysis of the clinical course of cases diagnosed
with SNADA at each institution provided clinically useful data.
Finally, the observation period to investigate adenoma prognosis
was relatively short to adenomas. In this study, only certain cases
were followed up for 1 year. However, 40 of 101 cases were
followed up for at least 3years, and 13 of 101 cases were followed
up for more than 5years. We believe that this was a sufficient
period to discuss the safety of no-resection as a treatment strategy.
In conclusion, SNADA tends to occur as small lesions in older
men. The low incidence of cancer development and no disease-
specific death demonstrate that the strategy of initially not
performing resection could be one of the considered treatment
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